Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10035966HBVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS30067436HIVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061554HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061565HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS20061861HPVENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44008599HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TVIS44039492HTLV-1ENSG00000085563.15protein_codingABCB1YesNo5243A4D1D2
P08183
TCGA Plot Options
Drug Information
GeneABCB1
DrugBank IDDB16407
Drug NameAzvudine
Target IDBE0001032
UniProt IDP08183
Regulation Typeactivator
PubMed IDs28487144
CitationsLiu Y, Liu B, Zhang Y, Peng Y, Huang C, Wang N, Jiang J, Wang Q, Chang J: Intestinal absorption mechanisms of 2'-deoxy-2'-beta-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein. Eur J Pharm Sci. 2017 Jul 15;105:150-158. doi: 10.1016/j.ejps.2017.05.009. Epub 2017 May 6.
GroupsInvestigational
Direct Classification
SMILESNC1=NC(=O)N(C=C1)[C@@H]1O[C@@](CO)(N=[N+]=[N-])[C@@H](O)[C@@H]1F
Pathways
PharmGKB
ChEMBLCHEMBL519846